These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9286624)

  • 1. Chronic treatment with BRL 35135 potentiates the action of insulin on lipid metabolism.
    Virtanen KA; Rouru J; Hänninen V; Savontaus E; Rouvari T; Teirmaa T; Koulu M; Huupponen R
    Eur J Pharmacol; 1997 Aug; 332(2):215-8. PubMed ID: 9286624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of metabolic disorders and visceral fat obesity by the beta 3-adrenoceptor agonist (R*,R*)-(+/-)-methyl-4-[2-[2-hydroxy-2 -(3-chlorophenyl)ethylamino]propyl]-phenoxyacetate hydrobromide (BRL35135A) in genetically obese rodents.
    Hashimoto K; Nagao Y; Ida K; Takeda M; Murakami N; Kato K; Mizota M
    Biochem Pharmacol; 1996 Nov; 52(10):1529-35. PubMed ID: 8937467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute injection of beta-adrenoceptor agonist BRL 35135 corrects both impaired uncoupling protein and lipoprotein lipase gene expression but not hypercapacity of lipogenesis in brown adipose tissue of suckling fa/fa rats.
    Marie V; Dupuy F; Bazin R
    Int J Obes Relat Metab Disord; 1994 May; 18(5):273-9. PubMed ID: 7914794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation of the anti-obesity effect of the selective beta 3-adrenoceptor agonist BRL 35135 in obese Zucker rats by exercise.
    Santti E; Huupponen R; Rouru J; Hänninen V; Pesonen U; Jhanwar-Uniyal M; Koulu M
    Br J Pharmacol; 1994 Dec; 113(4):1231-6. PubMed ID: 7889277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoid X receptor agonists have anti-obesity effects and improve insulin sensitivity in Zucker fa/fa rats.
    Liu YL; Sennitt MV; Hislop DC; Crombie DL; Heyman RA; Cawthorne MA
    Int J Obes Relat Metab Disord; 2000 Aug; 24(8):997-1004. PubMed ID: 10951538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of uncoupling proteins by chronic treatments with beta 3-adrenergic agonist BRL 35135 and metformin in obese fa/fa Zucker rats.
    Savontaus E; Rouru J; Boss O; Huupponen R; Koulu M
    Biochem Biophys Res Commun; 1998 May; 246(3):899-904. PubMed ID: 9618309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of BRL 26830, a novel beta-adrenoceptor agonist, on glucose tolerance, insulin sensitivity and glucose turnover in Zucker (fa/fa) rats.
    Smith SA; Levy AL; Sennitt MV; Simson DL; Cawthorne MA
    Biochem Pharmacol; 1985 Jul; 34(14):2425-9. PubMed ID: 2861816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the beta-adrenoceptor agonist BRL-35135 on development of obesity in suckling Zucker (fa/fa) rats.
    Charon C; Dupuy F; Marie V; Bazin R
    Am J Physiol; 1995 Jun; 268(6 Pt 1):E1039-45. PubMed ID: 7611376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of the beta3-adrenoceptor agonist BRL 35135 on UCP isoform mRNA expression.
    Emilsson V; Summers RJ; Hamilton S; Liu YL; Cawthorne MA
    Biochem Biophys Res Commun; 1998 Nov; 252(2):450-4. PubMed ID: 9826550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRL 35135, a potent and selective atypical beta-adrenoceptor agonist.
    Cawthorne MA; Sennitt MV; Arch JR; Smith SA
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):252S-257S. PubMed ID: 1345889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of novel beta-adrenoceptor agonists on carbohydrate metabolism: relevance for the treatment of non-insulin-dependent diabetes.
    Cawthorne MA; Carroll MJ; Levy AL; Lister CA; Sennitt MV; Smith SA; Young P
    Int J Obes; 1984; 8 Suppl 1():93-102. PubMed ID: 6152558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermogenic and antiobesity activity of a novel beta-adrenoceptor agonist (BRL 26830A) in mice and rats.
    Arch JR; Ainsworth AT
    Am J Clin Nutr; 1983 Oct; 38(4):549-58. PubMed ID: 6137948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
    Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
    Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effects of the beta 3-adrenoceptor agonist, BRL 35135, on tissue glucose utilisation.
    Liu YL; Stock MJ
    Br J Pharmacol; 1995 Feb; 114(4):888-94. PubMed ID: 7773551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a novel thermogenic beta-adrenoceptor agonist (BRL 26830) on insulin resistance in soleus muscle from obese Zucker rats.
    Challiss RA; Budohoski L; Newsholme EA; Sennitt MV; Cawthorne MA
    Biochem Biophys Res Commun; 1985 Apr; 128(2):928-35. PubMed ID: 2986630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic effects of three weeks administration of the beta-adrenoceptor agonist BRL 26830A.
    Connacher AA; Bennet WM; Jung RT; Rennie MJ
    Int J Obes Relat Metab Disord; 1992 Sep; 16(9):685-94. PubMed ID: 1356939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic administration of BRL 26830A for 9 weeks improves insulin sensitivity but does not prevent weight gain in gold-thioglucose obese mice.
    Bryson JM; Wensley VR; Phuyal JL; Caterson ID; Cooney GJ
    Horm Metab Res; 1999 May; 31(5):317-22. PubMed ID: 10422727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-adrenoceptor subtypes mediating the metabolic effects of BRL 35135 in man.
    Wheeldon NM; McDevitt DG; McFarlane LC; Lipworth BJ
    Clin Sci (Lond); 1994 Mar; 86(3):331-7. PubMed ID: 7908864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved glycemic control in C57Bl/KsJ (db/db) mice after treatment with the thermogenic beta-adrenoceptor agonist, BRL 26830.
    Carroll MJ; Lister CA; Sennitt MV; Stewart-Long N; Cawthorne MA
    Diabetes; 1985 Nov; 34(11):1198-204. PubMed ID: 2864298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-hyperglycaemic action of BRL 26830, a novel beta-adrenoceptor agonist, in mice and rats.
    Sennitt MV; Arch JR; Levy AL; Simson DL; Smith SA; Cawthorne MA
    Biochem Pharmacol; 1985 Apr; 34(8):1279-85. PubMed ID: 2859857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.